Trials / Sponsors / Tessa Therapeutics
Tessa Therapeutics
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy Classical Hodgkin Lymphoma, Hodgkin Disease Refractory, Hodgkin Disease Recurrent | Phase 1 | 2022-07-25 |
| Active Not Recruiting | Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma Anaplastic Large Cell Lymphoma, Peripheral T Cell Lymphoma, Extranodal NK/T-cell Lymphoma | Phase 1 | 2021-09-08 |
| Active Not Recruiting | Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CH Hodgkin Lymphoma, Adult, Hodgkin Disease Recurrent, Hodgkin Disease Refractory | Phase 2 | 2021-02-01 |
| Completed | A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patien Nasopharyngeal Carcinoma | Phase 3 | 2014-07-01 |